Article Text

PDF
FRI0011 Type I IFN inhibits arthritis via down-modulation of arthritogenic T-cell proliferation and cytokine production but independently of the enzymatic activity of IDO
  1. M. Magnusson1,
  2. J.P. Chalise2,
  3. S.C. Narendra2
  1. 1Autoimmunity & Immune Regulation, Clinical & Experimental Medicine, LinkÖPing
  2. 2Autoimmunity & Immune Regulation, IKE, Linköping, Sweden

Abstract

Background The cytokine interferon-alpha (IFNa) may induce adaptive-immunity independent arthritis if present in the joint (1) but may in contrast prevent antigen-induced arthritis if activated during immunisations (2). Here we investigate if this is due to tolerance development in terms of antigen-specific proliferation and cytokine release and evaluate the role of the tolerance-inducing enzyme indoleamine 2, 3 dioxygenase (IDO).

Objectives To determine the importance of IDO for the protective effect of IFNa against mBSA-induced arthritis and to determine how presence of IFNa in the sensitization phase of mBSA-induced arthritis affects antigen-specific proliferation and cytokine release.

Methods Arthritis was induced in pre-sensitized animals (mBSA in Freunds adjuvant with or without addition of IFNa on day 0 and day 7) by intra-articular injection of mBSA in the left knee. PBS was injected in the right knee. IDO was inhibited by inserting a 1-methyl tryptophan releasing pellet under the skin at day 0 or day 21. Placebo-pellet were inserted in the control group. Antigen-specific proliferation was determined by radio immunoassay. Levels of different cytokines were determined by Luminex technology.

Results Type I IFN-mediated protection was associated with diminished antigen-specific proliferation during the immunisation course and inhibited increased production of IL-17, TNF, IFN-gamma, IL-12, IL-1b but not IL-6 after intra-articular challenge. Thus IFNa induces a state of tolerance towards the antigen, which may explain its protective effect in mBSA-induced arthritis. An important mediator of immunological tolerance is the enzyme indoleamine 2, 3 dioxygenase. To determine the role of IDO in IFNa-mediated protection against antigen-induced arthritis, the IDO activity was inhibited by 1-methyl tryptophan (1-MT), a specific inhibitor of the IDO-mediated transformation of tryptophan to kynurenine. Presence of 1-MT-releasing tablets under the skin of mice from the first immunization and onwards slightly, but not significantly diminished the protective effect of IFNa. Insertion of 1-MT-releasing pellet at the time of intra-articular challenge had no effect on IFNa-mediated protection. No significant effect of 1-MT on antigen-specific proliferation was observed.

Conclusions Thus mechanisms independent of the enzymatic activity of IDO are responsible for the protective effect of IFNa in mBSA-induced arthritis.

  1. Magnusson, Zare & Tarkowski., Arthritis & Rheum. 2006. Jan;54(1):148-57

  2. Ying, Chalise, Narendra & Magnusson, Eur. J. Immunol., 2011. Jun;41(6):1687-95

Disclosure of Interest None Declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.